Quebec – Montreal – Saint-Laurent
Corporation
www.methylgene.com
Quebec
Montreal
Saint-Laurent
Corporation
active
MethylGene is a publicly-traded biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics in cancer and infectious diseases. We intend to exploit our HDAC inhibitor technology in other diseases, such as diabetes, inflammation, fungal infections and neurodegenerative disorders. Two cancer product candidates are currently in clinical trials: MGCD0103, partnered with Pharmion Corporation and Taiho Pharmaceutical Co., Ltd., and MG98, partnered with MGI Pharma, Inc. MethylGene has an exclusive license agreement with Merck - Co. for the development and commercialization of small molecule beta-lactamase inhibitors to overcome antibiotic resistance. MethylGene has partnered its non-oncology HDAC program for neurodegenerative diseases with EnVivo Pharmaceuticals. MethylGene has a portfolio of preclinical programs for its multi-targeted kinase and histone deacetylase (HDAC) inhibitors for both oncology and non-oncology indications, and continues to seek partnering opportunities in these areas.
MethylGene has received $41.9 million of investment and funding
from Venture Capitalists, including a $4.8 million award from
Technology Partnerships Canada. The company has also raised
US$17.2 million in equity and upfront payments from their
partners.
Country of Ownership: Canada
Year Established: 1996
Exporting: No
Primary Industry (NAICS): 325410 - Pharmaceutical and Medicine Manufacturing
Alternate Industries (NAICS): 541380 - Testing Laboratories
541710 - Research and Development in the Physical, Engineering and Life Sciences
Primary Business Activity: Services
Number of Employees: 104
Services:
Pharmaceutical products
Products:
Mgcd0103 hdac inhibitor in clinical trials for oncology
Technology:
MethylGene is a chemistry-driven company with broad in-house
expertise in a number of key areas in drug discovery and development, including, medicinal chemistry, combinatorial chemistry, analytical chemistry, bioanalytical chemistry, enzymology, functional genomics and in vivo pharmacology.
Besterman Jeffrey M.
C. Martin Godbout, O.
Corcoran Donald F.
Drutz David J.
Grubsztajn Charles
No associations
LandOfFree
MethylGene Inc. does not yet have a rating. At this time, there are no reviews or comments for this company.
If you have personal experience with MethylGene Inc., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and MethylGene Inc. will most certainly appreciate the feedback.
Profile ID: LFCA-COD-O-29810